AstraZeneca (AZN) Stock Is Plunging After Long Volatility: What’s The Buzz?

Since the beginning of the year, AstraZeneca (AZN) has been moving volatile, there were moments of attempts at sharp growth, which were unsuccessful. But there was still an increase, since the stock rose by 12% in 2021, given that the stock recently began to fall. On July 2, the price was at its peak ($60.79), but then the fall began.
Смотреть исходное изображениеA new strain of the Delta virus has appeared in the world, which is even more contagious than the original strain found in China. Doctors from Chile recommend giving patients a third dose of the vaccine, a “booster dose”, to provide protection against viral mutations. Dr. Alexis Kalergis, who conducted clinical research with 2,000 volunteers, said that less than 3% became infected with COVID-19 six months after receiving the second shot of the vaccine.

Many countries in Asia and South America prefer Chinese vaccines to protect against CAVID-19, but now there are doubts whether they provide full and long-term protection against this new strain of the virus. Thailand said it will use the AstraZeneca vaccine as a second dose for those who received Sinovac as the first to increase protection.

Richard McEntire

Finance and Entertainment Reporter Richard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.

Want Hot Stocks?    Yes. I Love Them No thanks